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Strengths and limitations of this study
 Ź State-of-the-art synthesis of evidence on low-value 
clinical practices in the care of acute traumatic brain 
injury (TBI).
 Ź Represents a crucial step towards the deimplemen-
tation of low-value practices in acute TBI care.
 Ź Adopts an integrated knowledge translation model 
to ensure the results are relevant to decision makers.
 Ź For feasibility reasons, our synthesis is restricted to 
systematic reviews published in English since 1990.
 Ź The scope of review and the inclusion of systematic 
reviews precludes meta-analysis.
AbStrACt
Introduction Traumatic brain injury (TBI) leads to 50 000 
deaths, 85 000 disabilities and costs $60 billion each year 
in the USA. Despite numerous interventions and treatment 
options, the outcomes of TBI have improved little over 
the last three decades. In a previous scoping review and 
expert consultation survey, we identiied 13 potentially 
low-value clinical practices in acute TBI. The objective 
of this umbrella review is to synthesise the evidence on 
potentially low-value clinical practices in the care of acute 
TBI.
Methods and analysis Using umbrella review 
methodology, we will search Cochrane Central Register 
of Controlled Trials, Embase, Epistemonikos, International 
Prospective Register of Systematic Reviews (PROSPERO) 
and PubMed to identify systematic reviews evaluating the 
effect of potential intrahospital low-value practices using 
tailored population, intervention, comparator, outcome and 
study design questions based on the results of a previous 
scoping review. We will present data on the methodological 
quality of these reviews (Assessing the Methodological 
Quality of Systematic Reviews-2), reported effect sizes 
and strength of evidence (Grading of Recommendations, 
Assessment, Development and Evaluation).
Ethics and dissemination Ethics approval is not required 
as original data will not be collected. Knowledge users 
from ive healthcare quality organisations and clinical 
associations are involved in the design and conduct of the 
study. Results will be disseminated in a peer-reviewed 
journal, at international scientiic meetings and to clinical, 
healthcare quality and patient–partner associations. This 
work will support the development of metrics to measure 
the use of low-value practices, inform policy makers on 
potential targets for deimplementation and in the long term 
reduce the use of low-value clinical practices in acute TBI 
care.
PrOSPErO registration number CRD42019132428.
IntrOduCtIOn
Traumatic brain injury (TBI) is the main 
cause of mortality from injury in people 
under 45 years of age,1 and it leads to 
approximately US$60 and €33 billion in 
total medical costs in the USA2 and Europe3 
each year, respectively. Moreover, outcomes 
following TBI have not improved signifi-
cantly in the last four decades.4 5 Interven-
tion and treatment options for TBI are 
multiple, but many lack robust evidence of 
their effectiveness.6 7
Low-value clinical practices, defined as 
a test or procedure that is not supported 
by evidence and/or could expose patients 
to unnecessary harm8–15 consume up to 
30% of healthcare budgets.9 16 In the past 
decade, the medical community has turned 
towards the deimplementation of low-value 
practices as a promising means to reduce 
the strain on healthcare budgets, free-up 
resources and reduce harm to patients.17 
Physicians report using low-value practices 
because of a lack of alternative treatment 
options, fear of legal consequences but also 
because of lack of guidelines on low-value 
care.15 18 The Brain Trauma Foundation, 
among others, publish guidelines on TBI 
care.19 However, emphasis is on practices 
that should be adhered to rather than 
practices that should be avoided. Choosing 
Wisely publish recommendations specifi-
cally targeting low-value practices but few 
pertain to TBI care and many are based 
uniquely on expert consensus.11 A previous 
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Table 1 PICOS for each clinical practice
# Clinical practice
Mild traumatic brain injury
1 Population: adults with acute mild traumatic brain 
injury
Intervention: validated clinical decision rule (eg, 
CCHR, CHIP, NEXUS II, NOC)
Comparator: none
Primary outcome: false negative rate (intracranial 
injury, neurosurgical intervention)
Secondary outcomes: sensitivity, speciicity
Study design: systematic review
2 Population: adults with acute mild complicated 
traumatic brain injury
Intervention: routine repeat head CT in absence of 
neurological deterioration
Comparator: none or no repeat head CT in absence 
of neurological deterioration
Primary outcome: progression of intracranial injury
Secondary outcomes: neurosurgical intervention, 
mortality, change in management, hospital length of 
stay
Study design: systematic review
3 Population: adults with acute mild traumatic brain 
injury and on anticoagulant and/or antiplatelet 
therapy
Intervention: routine repeat head CT in absence of 
neurological deterioration
Comparator: none or no repeat head CT in absence 
of neurological deterioration
Primary outcome: progression of intracranial injury
Secondary outcomes: neurosurgical intervention, 
mortality, change in management, hospital length of 
stay
Study design: systematic review
4 Population: adults with acute mild traumatic brain 
injury who are negative on head CT
Intervention: neurosurgical consultation
Comparator: none or no neurosurgical consultation
Primary outcome: hospital admission
Secondary outcomes: neurosurgical intervention, 
mortality, ICU admission, repeat head CT, hospital 
length of stay
Study design: systematic review
5 Population: adults with acute mild complicated 
traumatic brain injury who are not on irreversible 
anticoagulation
Intervention: intensive care unit admission
Comparator: admission to regular ward or step-
down unit
Primary outcome: neurological/medical decline, 
neurosurgical intervention
Secondary outcomes: medical interventions, 
mortality, adverse events, hospital length of stay, 
discharge destination
Study design: systematic review
Moderate and severe traumatic brain injury
Continued
scoping review and expert consultation survey identi-
fied 13 potentially low-value clinical practices in acute 
TBI care.20 These practices represent potential targets 
for guidelines, overuse metrics and deimplementation 
interventions. However, before recommendations can 
be made, we need to synthesise the evidence base for 
these practices.
Interventions and treatment options for acute TBI 
have been the subject of multiple systematic reviews.21 22 
Given this large body of available evidence, evidence 
maps have previously been used to summarise evidence 
from systematic reviews on acute TBI interventions.7 23 
However, these evidence maps were not designed to 
target low-value practices and focused on moderate to 
severe TBI when the mild TBI population represent 
great potential for reducing low-value care. In addi-
tion, previous reviews have not provided a synthesis of 
effect sizes or strength of evidence. The objective of the 
present study is to synthesise the evidence on poten-
tially low-value intrahospital clinical practices in acute 
adult TBI.
MEthOdS And AnAlySIS
Given the multitude of systematic reviews available for 
the clinical practices identified as potentially low-value 
(over 60 were identified in our scoping review), we 
opted to conduct an umbrella review (a systematic 
review of systematic reviews).20 While the former aimed 
to fill a knowledge gap on medical overuse for acute 
injury care by identifying all potential low-value clinical 
practices, the latter will synthesise the evidence on the 
low-value practices pertaining to TBI. The review will be 
conducted according to published guidelines.24–26 In the 
absence of reporting guidelines for umbrella reviews, 
we will use the applicable Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
Protocols.27
Eligibility criteria
The project steering committee comprising clinicians 
(two emergency physicians, seven critical care physi-
cians, one neurosurgeon), methodologists (four) and 
health system managers (three) used the population, 
intervention, comparator, outcome and study design 
(PICOS) framework to develop specific research ques-
tions for each potentially low-value clinical practice 
(table 1).20 28 We will consider systematic reviews of 
original studies evaluating the effectiveness of prede-
termined clinical practices in acute TBI in adults (≥16 
years old) without restriction on location of publica-
tion but limited to studies published in English since 
1990.25 26
We will use the Cochrane definition to identify system-
atic reviews. We will consider a review to be systematic if 
it clearly stated a set of objectives and reported explicit 
eligibility criteria, an extensive search strategy (a refined 
search strategy ran on Medline or Cochrane Library 
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# Clinical practice
6 Population: adults with acute traumatic brain injury 
on antiplatelet therapy
Intervention: platelet transfusion
Comparator: no platelet transfusion
Primary outcome: GOS or GOS-E
Secondary outcomes: mortality, adverse events, 
hospital and ICU length of stay
Study design: systematic review
7 Population: adults with basal skull fractures without 
evidence of cerebrospinal luid leakage
Intervention: antibiotic prophylaxis
Comparator: no antibiotic prophylaxis
Primary outcome: meningitis (conirmed by lumbar 
puncture)
Secondary outcomes: GOS or GOS-E, mortality, 
surgical correction in patients with CSF leakage, 
non-CNS infection, hospital and ICU length of stay
Study design: systematic review
8 Population: adults with acute traumatic brain injury 
and no refractory intracranial hypertension
Intervention: therapeutic hypothermia
Comparator: no therapeutic hypothermia
Primary outcome: GOS or GOS-E
Secondary outcomes: intracranial pressure, 
mortality, adverse events, hospital and ICU length of 
stay
Study design: systematic review
9 Population: adults with acute traumatic brain injury
Intervention: antibiotic prophylaxis for external 
ventricular drain placement
Comparator: no antibiotic prophylaxis
Primary outcome: ventriculostomy-related infection
Secondary outcomes: GOS, mortality, hospital and 
ICU length of stay
Study design: systematic review
10 Population: adults with acute traumatic brain injury 
and no refractory intracranial hypertension
Intervention: neuromuscular blocking agents
Comparator: no neuromuscular blocking agents
Primary outcome: GOS or GOS-E
Secondary outcomes: intracranial pressure, 
mortality, adverse events, hospital and ICU length of 
stay
Study design: systematic review
11 Population: adults with acute traumatic brain injury
Intervention: plasma transfusion
Comparator: no plasma transfusion
Primary outcome: GOS or GOS-E
Secondary outcomes: mortality, adverse events, 
hospital and ICU length of stay
Study design: systematic review
Severe traumatic brain injury
Table 1 Continued
Continued
# Clinical practice
12 Population: adults with acute severe traumatic brain 
injury
Intervention: albumin
Comparator: any other colloid-containing luids 
(dextrans, modiied gelatins, hydroxyethyl starches) 
or isotonic crystalloid luids (saline 0.9% and 
balanced salt solutions such as compound sodium 
lactate, Plasma-Lyte)
Primary outcome: GOS or GOS-E
Secondary outcomes: mortality, adverse events, 
hospital and ICU length of stay
Study design: systematic review
13 Population: adults with acute severe traumatic brain 
injury
Intervention: antiseizure prophylaxis (levetiracetam 
or phenytoin)>1 week
Comparator: antiseizure prophylaxis <1 week or no 
antiseizure prophylaxis
Primary outcome: late post-traumatic seizure
Secondary outcomes: GOS or GOS-E, mortality, 
adverse events, hospital and ICU length of stay
Study design: systematic review
CCHR, Canadian Computed Tomography Head Rule; CHIP, 
CT in head injury patients; CNS, central nervous system; CSF, 
cerebrospinal luid; GOS, Glasgow Outcome Scale; GOS-E, 
Glasgow Outcome Scale-Extended; ICU, intensive care unit; 
NEXUS, National Emergency X-Radiography Utilisation Study; 
NOC, New Orleans Criteria; PICOS, population, intervention, 
comparator, outcome and study design.
Table 1 Continued
and at least one other database)29 30 and reproducible 
methods to identify, select and critically appraise the 
findings of the included studies.24
Outcomes
Primary and secondary outcomes were identified for each 
of the evaluated clinical practices by the project steering 
committee and are described in a PICO format in table 1.
Search strategy
In consultation with an information specialist, we will 
develop comprehensive literature search strategies sepa-
rately for each clinical practice to be studied (see table 2 
for a preliminary search strategy in PubMed). We will 
search systematic reviews using the Cochrane Library, 
Excerpta Medica Database (Embase), Epistemonikos,31 
PubMed and the International Prospective Register of 
Systematic Reviews32 from 1990 to up to 6 months prior to 
submission for publication. Using a snowball approach, 
we will screen the references of included studies in addi-
tion to previous reviews on this subject.7 21–23 33
Selection process
We will manage all citations with EndNote software V.X8.2 
(Clarivate Analytics, 2014). We will identify and remove 
duplicates using electronic and manual screening.34 
To ensure reliability when selecting studies for a given 
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Table 2 Search strategy for hypothermia in PubMed
Concepts PubMed search strategy Research
Injury “Craniocerebral Trauma”[Majr] OR [diffus* AND axonal injur*[Title/Abstract]] OR 
“head trauma”[Title/Abstract]OR “head injury”[Title/Abstract]OR “head injuries”[Title/
Abstract]OR “brain trauma”[Title/Abstract]OR “brain injury”[Title/Abstract]OR “brain 
injuries”[Title/Abstract]OR “cerebral trauma”[Title/Abstract]OR “cerebral injury”[Title/
Abstract]OR “cerebral injuries”[Title/Abstract]OR “craniocerebral trauma”[Title/Abstract]
OR “craniocerebral injury”[Title/Abstract]OR “craniocerebral injuries”[Title/Abstract]
OR “TBI”[Title/Abstract]OR “traumatic brain injury”[Title/Abstract]OR “traumatic brain 
injuries”[Title/Abstract]OR “brainstem trauma”[Title/Abstract]OR “brainstem injury”[Title/
Abstract]OR “brainstem injuries”[Title/Abstract]OR “Head Injuries, Closed”[MeSH:NoExp]
OR “Brain Injuries”[MeSH:NoExp]OR “Craniocerebral Trauma”[MeSH:NoExp]OR “Brain 
Hemorrhage, Traumatic”[MeSH] OR “Diffuse Axonal Injury”[MeSH:NoExp]OR “Coma, Post-
Head Injury”[MeSH:NoExp]OR “Head Injuries, Penetrating”[MeSH:NoExp]OR “Intracranial 
Hemorrhage, Traumatic”[MeSH] OR “Skull Fractures”[MeSH]
#1
Clinical practice “Hypothermia”[Mesh] OR “Cryotherapy”[Mesh] OR “Body Temperature”[Mesh] OR “artiicial 
hibernation”[Title/Abstract]OR “body cooling”[Title/Abstract]OR cold*[Title/Abstract]OR 
cool*[Title/Abstract]OR “cooling therapy”[Title/Abstract]OR “cooling therapies”[Title/Abstract]
OR cryogen*[Title/Abstract]OR cryother*[Title/Abstract]OR cryotreat*[Title/Abstract]OR 
hypotherm*[Title/Abstract]OR normotherm*[Title/Abstract]OR refrigeration*[Title/Abstract]OR 
temperature*[Title/Abstract]
#2
Filter for 
systematic 
reviews
(((systematic review[ti] OR systematic literature review[ti] OR systematic scoping review[ti] OR 
systematic narrative review[ti] OR systematic qualitative review[ti] OR systematic evidence 
review[ti] OR systematic quantitative review[ti] OR systematic meta-review[ti] OR systematic 
critical review[ti] OR systematic mixed studies review[ti] OR systematic mapping review[ti] OR 
systematic cochrane review[ti] OR systematic search and review[ti] OR systematic integrative 
review[ti]] NOT comment[pt] NOT [protocol[ti] OR protocols[ti]]) NOT MEDLINE [subset]) OR 
(Cochrane Database Syst Rev[ta] AND review[pt)] OR systematic review[pt]
#3
Total #1 AND #2 AND #3 #4
practice, two sets of 100 citations will independently be 
evaluated and then discussed by the reviewers. Pairs of 
reviewers (PAT, LM, IF, KMB) will then independently 
screen all identified records using titles, abstracts and full 
texts, consecutively. Any disagreement will be resolved 
through discussion between reviewers and, if necessary, 
consultation with a senior author (AFT). Potentially 
eligible studies excluded using full texts will be described 
in a PRISMA flow chart.
data items and abstraction process
Using a standardised data abstraction form piloted on a 
representative sample of five studies, pairs of experienced 
reviewers (PAT, LM, IF, KMB) will independently extract 
the following data: first author, title, year of publication, 
databases used and date of the last search; population(s), 
intervention(s), comparator(s), outcome(s) and study 
designs included; measures of association and their 
respective measure of heterogeneity; tools used to assess 
the quality (risk of bias) of original studies and overall 
rating from the authors. Any disagreement will be resolved 
through discussion between reviewers and, if necessary, 
consultation with a senior author (AFT). When informa-
tion is available in figures only, we will abstract graphical 
data using computer-assisted software.35 36 Furthermore, 
we will contact study authors (up to three email attempts) 
when information is unclear or unavailable.
Methodological quality assessment
Two reviewers (PAT, LM) will independently critically 
appraise the quality of systematic reviews using the 
Assessing the Methodological Quality of Systematic Reviews 
(AMSTAR-2) tool.37 Methodological quality will be catego-
rised as low (0–3), medium (4–7) and high (8–11).
Synthesis
Results will be presented according to current recom-
mendations for umbrella reviews.38 For each low-value 
practice, we will present the number of studies, study 
designs and patients included, the quality of the reviews 
(AMSTAR-2), effect sizes for primary and secondary 
outcomes (forest plots) and strength of recommenda-
tions (Grading of Recommendations, Assessment, Devel-
opment and Evaluation).
Potential limitations
To ensure the feasibility of the review, we will restrict our 
search to low-value practices identified in the scoping 
review and expert consultation study, which may lead 
us to miss some low-value practices. However, given the 
robust search strategy used in our scoping review and the 
fact that experts were asked to add any other practices 
they considered low value, it is unlikely that important 
low-value practices have been missed. By targeting system-
atic reviews rather than original studies, we may miss some 
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evidence. However, given the availability of high-quality, 
up-to-date reviews in TBI care suggested by our scoping 
review, we think it unlikely that we will miss a large body of 
evidence. For certain clinical practices, we may not iden-
tify any high-quality, up-to-date reviews. These practices 
will be the subject of systematic reviews in subsequent 
phases of the research programme. Finally, for feasi-
bility reasons, we limited this umbrella review to reviews 
published in English since 1990 as per recommendations 
for umbrella reviews.25 26 These limitations should have 
negligible impact on results since few systematic reviews 
were published prior to 1990 and most published reviews 
are likely to be written in English.25 26
Potential impact
This review is part of the Canadian Program on Moni-
toring Low-Value Clinical Practices in Injury Care (Cana-
dian Institutes of Health Research #113664), aiming to 
evaluate the effectiveness of an audit-feedback module 
targeting low-value clinical practices in acute injury 
care. The results of this review will be used to inform the 
development of quality indicators to be integrated in the 
audit-feedback module.
We will use state-of-the-art methods to optimise the sensi-
tivity of our search strategy and the robustness of results. 
Results will be synthesised graphically. Ultimately, this 
research will inform the development of metrics, guide-
lines and deimplementation interventions, all targeting 
low-value injury care. The reduction of low-value clinical 
practices in acute TBI care has the potential to reduce 
pressure on strained healthcare budgets, free up resources, 
reduce adverse events and improve patient outcomes.
Ethics and dissemination
Ethics approval is not required as original data will 
not be collected. This study will be disseminated in a 
peer-reviewed journal, international scientific meetings, 
to knowledge users through clinical and healthcare 
quality associations (Choosing Wisely Canada, Trauma 
Association of Canada, American College of Surgeons—
Committee on Trauma, International Federation of Emer-
gency Medicine, Institut national d’excellence en santé 
et en services sociaux, Brain Trauma Foundation) and to 
patient partners associations (Brain Injury Canada).
Patient and public involvement
No patient or public representatives will be involved in 
this study.
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